To investigate ST2 (also known as IL1RL1) expression in brain tumors, we analyzed publicly available GBM datasets for ST2 mRNA expression from GBM cohorts26–28 and observed a reduction of ST2 levels in GBM patients, compared to the control brain25 (Supplementary Figure S2C). The gene discussed is IL1RL1; the disease is brain neoplasm.